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Background
The NO/cGMP/PKG pathway plays a crucial role in the
induction of cerebellar long term depression (LTD),
synaptic plasticity, and motor learning. Previous studies
showed that Purkinje cell specific PKG I knock-out
mice exhibit strongly reduced LTD and deficits in adap-
tation of the vestibular ocular reflex [1].
To better understand the molecular mechanisms of
PKG I and its involvement in LTD and motor learning,
we combined the use of a mouse model deficient for
PKG I expression with an LC-MS/MS based in-depth
proteomics and phosphoproteomics analysis directly in
cerebellum tissue.
Results
We compared the protein expression between cerebellum
tissues of 3 PKG I deficient and 3 wild-type litter mates.
This triplicate analysis yielded a comprehensive cerebel-
lum proteome of 6263 quantified proteins, of which 121
proteins were found to be significantly differentially
expressed in the PKG I knock-out mice. Differential
expressed proteins included those involved in calcium
handling, but also several phosphatases, kinases and
phosphodiesterases responded to the absence of PKG.
Next, we also probed changes at phosphorylation level.
Therefore, a selective phosphopeptide enrichment strat-
egy was employed. This allowed the identification and
quantification of almost 3500 unique phosphopeptides
of which a selected set was differentially regulated in the
PKGI-deficient mice. These data provides several leads
to follow to come to a better understanding of the cere-
bellum function of of PKG.
Conclusion
The combination of a transgenic mouse model with an
in-depth proteome and phosphoproteome approach pro-
vides a powerful platform to understand the molecular
biology downstream of PKG I in cerebellum.
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